Table of Content

Table of Contents

Global Drug-Eluting Bioabsorbable Stents Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Drug-Eluting Bioabsorbable Stents Market by Value
2.2.1 Global Drug-Eluting Bioabsorbable Stents Revenue by Type
2.2.2 Global Drug-Eluting Bioabsorbable Stents Market by Value (%)
2.3 Global Drug-Eluting Bioabsorbable Stents Market by Production
2.3.1 Global Drug-Eluting Bioabsorbable Stents Production by Type
2.3.2 Global Drug-Eluting Bioabsorbable Stents Market by Production (%)

3. The Major Driver of Drug-Eluting Bioabsorbable Stents Industry
3.1 Historical & Forecast Global Drug-Eluting Bioabsorbable Stents Demand
3.2 Largest Application for Drug-Eluting Bioabsorbable Stents (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Drug-Eluting Bioabsorbable Stents Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Drug-Eluting Bioabsorbable Stents Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Drug-Eluting Bioabsorbable Stents Average Price Trend
12.1 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in US (2018-2022)
12.2 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in Europe (2018-2022)
12.3 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in China (2018-2022)
12.4 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in Japan (2018-2022)
12.5 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in India (2018-2022)
12.6 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in Korea (2018-2022)
12.7 Market Price for Each Type of Drug-Eluting Bioabsorbable Stents in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Drug-Eluting Bioabsorbable Stents Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Drug-Eluting Bioabsorbable Stents

14. Drug-Eluting Bioabsorbable Stents Competitive Landscape
14.1 Medtronic
14.1.1 Medtronic Company Profiles
14.1.2 Medtronic Product Introduction
14.1.3 Medtronic Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 B.Braun Melsungen
14.2.1 B.Braun Melsungen Company Profiles
14.2.2 B.Braun Melsungen Product Introduction
14.2.3 B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Abbott Laboratories
14.3.1 Abbott Laboratories Company Profiles
14.3.2 Abbott Laboratories Product Introduction
14.3.3 Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Boston Scientific Corporation
14.4.1 Boston Scientific Corporation Company Profiles
14.4.2 Boston Scientific Corporation Product Introduction
14.4.3 Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Biosensors International
14.5.1 Biosensors International Company Profiles
14.5.2 Biosensors International Product Introduction
14.5.3 Biosensors International Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Terumo Corporation.
14.6.1 Terumo Corporation. Company Profiles
14.6.2 Terumo Corporation. Product Introduction
14.6.3 Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 MicroPort Scientific Corporation
14.7.1 MicroPort Scientific Corporation Company Profiles
14.7.2 MicroPort Scientific Corporation Product Introduction
14.7.3 MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Alvimedica
14.8.1 Alvimedica Company Profiles
14.8.2 Alvimedica Product Introduction
14.8.3 Alvimedica Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Biotronik
14.9.1 Biotronik Company Profiles
14.9.2 Biotronik Product Introduction
14.9.3 Biotronik Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Elixir Medical Corporation
14.10.1 Elixir Medical Corporation Company Profiles
14.10.2 Elixir Medical Corporation Product Introduction
14.10.3 Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Innovative Health Technologies
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Drug-Eluting Bioabsorbable Stents Industry (Volume)
Figure 2. Drug-Eluting Bioabsorbable Stents Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Drug-Eluting Bioabsorbable Stents Revenue in 2022
Figure 5. US Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Drug-Eluting Bioabsorbable Stents Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Drug-Eluting Bioabsorbable Stents Revenue, by Type (Million USD) (2018-2028)
Table 4. Drug-Eluting Bioabsorbable Stents Production, by Type (K Unit) (2018-2028)
Table 5. Drug-Eluting Bioabsorbable Stents Demand (K Unit) by Application (2018-2028)
Table 6. Drug-Eluting Bioabsorbable Stents Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Drug-Eluting Bioabsorbable Stents Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Drug-Eluting Bioabsorbable Stents Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Drug-Eluting Bioabsorbable Stents in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Medtronic Profiles
Table 61. Medtronic Drug-Eluting Bioabsorbable Stents Product Introduction
Table 62. Medtronic Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Medtronic Strategic initiatives
Table 64. B.Braun Melsungen Profiles
Table 65. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Product Introduction
Table 66. B.Braun Melsungen Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. B.Braun Melsungen Strategic initiatives
Table 68. Abbott Laboratories Profiles
Table 69. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Product Introduction
Table 70. Abbott Laboratories Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Abbott Laboratories Strategic initiatives
Table 72. Boston Scientific Corporation Profiles
Table 73. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Introduction
Table 74. Boston Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Boston Scientific Corporation Strategic initiatives
Table 76. Biosensors International Profiles
Table 77. Biosensors International Drug-Eluting Bioabsorbable Stents Product Introduction
Table 78. Biosensors International Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Biosensors International Strategic initiatives
Table 80. Terumo Corporation. Profiles
Table 81. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Product Introduction
Table 82. Terumo Corporation. Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Terumo Corporation. Strategic initiatives
Table 84. MicroPort Scientific Corporation Profiles
Table 85. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Product Introduction
Table 86. MicroPort Scientific Corporation Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. MicroPort Scientific Corporation Strategic initiatives
Table 88. Alvimedica Profiles
Table 89. Alvimedica Drug-Eluting Bioabsorbable Stents Product Introduction
Table 90. Alvimedica Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Alvimedica Strategic initiatives
Table 92. Biotronik Profiles
Table 93. Biotronik Drug-Eluting Bioabsorbable Stents Product Introduction
Table 94. Biotronik Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Biotronik Strategic initiatives
Table 97. Elixir Medical Corporation Profiles
Table 98. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Product Introduction
Table 99. Elixir Medical Corporation Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Elixir Medical Corporation Strategic initiatives
Table 101. Innovative Health Technologies Profiles
Table 102. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Product Introduction
Table 103. Innovative Health Technologies Drug-Eluting Bioabsorbable Stents Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Innovative Health Technologies Strategic initiatives